CD8A and cancer: As an indicator of an overall impact of DC transfers on the anticancer response, the number of CD8 T cells and NK cells relative to the number and size of tumors was calculated by dividing the total number of CD8 T cells or NK cells (S2C Fig) by the cancer score, and is presented in Fig 7F as CD8 T cell and NK cell ratios.